Last update 11 Dec 2025

DTwP rHepB Hib IPV vaccine (GlaxoSmithKline/Biological E.)

Overview

Basic Info

Drug Type
Prophylactic vaccine
Synonyms
DTwPHBVHIBIPV
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Infectious DiseasesNervous System DiseasesDigestive System Disorders+ [2]
Active Indication-
Inactive Indication
DiphtheriaHemophilus influenza infectionHepatitis B+ [3]
Originator Organization
Biological E. Ltd.Biological E. Ltd.GSK PlcGSK Plc
Active Organization-
Inactive Organization
GSK PlcGSK PlcBiological E. Ltd.Biological E. Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with DTwP rHepB Hib IPV vaccine (GlaxoSmithKline/Biological E.)
CTRI/2024/02/063223
/ Active, not recruitingPhase 2
A prospective randomised active controlled Phase-II safety and immunogenicity study with 3-doses of Biological E’s Liquid Hexavalent Vaccine (DTwP-rHepB-Hib-IPV) in 6-8 weeks old infants. - Nil
CTRI/2019/01/016891
/ CompletedPhase 1IIT
A prospective, single arm, Phase I open label study to assess the reactogenicity and safety of a combined liquid DTwP-rHepB-Hib-IPV vaccine when administered to healthy children 16-24 months of age as a single dose. - None
100 Clinical Results associated with DTwP rHepB Hib IPV vaccine (GlaxoSmithKline/Biological E.)
Login to view more data
100 Translational Medicine associated with DTwP rHepB Hib IPV vaccine (GlaxoSmithKline/Biological E.)
Login to view more data
100 Patents (Medical) associated with DTwP rHepB Hib IPV vaccine (GlaxoSmithKline/Biological E.)
Login to view more data
100 Deals associated with DTwP rHepB Hib IPV vaccine (GlaxoSmithKline/Biological E.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis BPhase 1
India
Biological E. Ltd.Biological E. Ltd.
08 Jan 2019
TetanusPhase 1
India
GSK PlcGSK Plc
25 Dec 2018
Whooping CoughPhase 1
India
Biological E. Ltd.Biological E. Ltd.
25 Dec 2018
Hemophilus influenza infectionPhase 1
India
Biological E. Ltd.Biological E. Ltd.
21 Dec 2018
DiphtheriaPhase 1
India
GSK PlcGSK Plc
18 Dec 2018
PoliomyelitisPhase 1
India
Biological E. Ltd.Biological E. Ltd.
17 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free